Search

Your search keyword '"Burgmans, M.C."' showing total 2 results
Start Over Author "Burgmans, M.C." Language undetermined
2 results on '"Burgmans, M.C."'

1. In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma

Author

Osanto, S., Woei-A-Jin, F.J.S.H., Coenraad, M.J., Weijl, N.I., Burgmans, M.C., and Burggraaf, J.

Subjects
Cancer Research, Science & Technology, Carcinoma, Hepatocellular, Oncology, Liver Neoplasms, Humans, Life Sciences & Biomedicine, Neoadjuvant Therapy
Abstract

This letter to the editor responds to comments from Rizzo et al on recently reported results of a phase II study of dovitinib therapy for hepatocellular carcinoma. ispartof: ONCOLOGIST vol:27 issue:12 pages:E977-E978 ispartof: location:England status: published

Published
2022

2. Preoperative imaging for colorectal liver metastases: a nationwide population-based study

Author

Elfrink, A.K.E., Pool, M., Werf, L.R. van der, Marra, E., Burgmans, M.C., Meijerink, M.R., Dulk, M. den, Boezem, P.B. van den, Riele, W.W. te, Patijn, G.A., Wouters, M.W.J.M., Leclercq, W.K.G., Liem, M.S.L., Gobardhan, P.D., Buis, C.I., Kuhlmann, K.F.D., Verhoef, C., Besselink, M.G., Grunhagen, D.J., Klaase, J.M., Kok, N.F.M., Dutch Hepatobiliary Audit Grp, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, Groningen Institute for Organ Transplantation (GIOT), Value, Affordability and Sustainability (VALUE), Surgery, CCA - Imaging and biomarkers, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, AGEM - Re-generation and cancer of the digestive system, Pediatrics, Obstetrics and gynaecology, and Neurology

Subjects
Male, Databases, Factual, IMPACT, Contrast Media, Logistic regression, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Medicine, Netherlands, Aged, 80 and over, Liver Neoplasms, General Medicine, Middle Aged, CHEMOTHERAPY, Magnetic Resonance Imaging, CANCER, Hospitals, 030220 oncology & carcinogenesis, HPB, Preoperative Period, Lower GI, Female, Original Article, Radiology, Colorectal Neoplasms, medicine.drug, CT, medicine.medical_specialty, RESECTION, lcsh:Surgery, Cancer Care Facilities, Preoperative care, Resection, 03 medical and health sciences, Medical imaging, MANAGEMENT, Humans, mri, METAANALYSIS, Aged, Fluorodeoxyglucose, fdg-pet/ct, business.industry, Cancer, Original Articles, lcsh:RD1-811, medicine.disease, DIAGNOSTIC PERFORMANCE, Population based study, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Logistic Models, Multivariate Analysis, business, Preoperative imaging
Abstract

Background In patients with colorectal liver metastases (CRLM) preoperative imaging may include contrast‐enhanced (ce) MRI and [18F]fluorodeoxyglucose (18F‐FDG) PET–CT. This study assessed trends and variation between hospitals and oncological networks in the use of preoperative imaging in the Netherlands. Methods Data for all patients who underwent liver resection for CRLM in the Netherlands between 2014 and 2018 were retrieved from a nationwide auditing database. Multivariable logistic regression analysis was used to assess use of ceMRI, 18F‐FDG PET–CT and combined ceMRI and 18F‐FDG PET–CT, and trends in preoperative imaging and hospital and oncological network variation. Results A total of 4510 patients were included, of whom 1562 had ceMRI, 872 had 18F‐FDG PET–CT, and 1293 had combined ceMRI and 18F‐FDG PET–CT. Use of ceMRI increased over time (from 9·6 to 26·2 per cent; P, A nationwide population‐based overview from 2014 to 2018 in the Netherlands showed an increased use of contrast‐enhanced MRI and decreased use of PET–CT. There was significant hospital variation in the use of both MRI and PET–CT. Wide variation in the use of preoperative MRI and FDG‐PET‐CT

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results